BUSINESS

• Shionogi Ups Earnings Forecast for April-September
  October 25, 2016

• Ono Files Patent Infringement Suit over Keytruda
  October 25, 2016

• Nihon Generic Takes Over 3 Brands from MSD
  October 24, 2016

• Prasugrel Disappoints in PIII Study for Ischemic Cerebrovascular Disease
  October 24, 2016

• 295 Staffers Applied for Voluntary Redundancy: Sumitomo Dainippon
  October 24, 2016

• Daiichi Sankyo Stops Patient Enrollment for Pexidartinib PIII, but Continues Study
  October 24, 2016

• Oncolys, DNA Chip Research Team Up to Study Potential of TelomeScan as Companion Diagnostic for CRPC
  October 24, 2016

• Kipres Generics Might Add Bronchial Asthma Indication before December Listing
  October 21, 2016

• Janssen Files Anti-IL-6 Antibody Sirukumab for RA
  October 21, 2016

• Humira Biosimilar Hits Primary Endpoint in Global PIII: Fujifilm, Kyowa Kirin
  October 20, 2016

• Kaketsuken’s Biz Transfer Talks Fall Apart, but Minister Nixes Its Continued Operations
  October 20, 2016

• Astellas Calls Off Biz Transfer Talks with Kaketsuken
  October 19, 2016

• UK’s Clinigen Launches Japan Operations with Takeover of Foscavir
  October 19, 2016

• Kaketsuken Denies Unauthorized Manufacturing or Cover-up, Blames Ambiguity in Approval Doc
  October 19, 2016

• Entyvio’s Real-World Data Support Trial Results: Takeda
  October 18, 2016

• Ethical Drug Sales Up 2.7% in August: Crecon Report
  October 18, 2016

• JT Grants S. Korea Rights for Anemia Drug to JW Pharmaceutical
  October 17, 2016

• PDUFA Date for COPD Drug Set for May 29, 2017: Sunovion
  October 17, 2016

• Sandoz Will Outpace Generic Market Growth: New Japan Chief
  October 14, 2016

• Gilead Japan Trying to Dig Up Untreated Hep C Patients as Demand Ebbs
  October 14, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 454
• 455
• 456
• 457
• 458
• 459
• 460
• 461
• 462
• …
• Next ›
• 最終 »